Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.

@article{Miller2002BupropionIN,
  title={Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.},
  author={Dennis K. Miller and Sangeetha P. Sumithran and Linda P. Dwoskin},
  journal={The Journal of pharmacology and experimental therapeutics},
  year={2002},
  volume={302 3},
  pages={1113-22}
}
Bupropion, an efficacious antidepressant and smoking cessation agent, inhibits dopamine and norepinephrine transporters (DAT and NET, respectively). Recently, bupropion has been reported to noncompetitively inhibit alpha3beta2, alpha3beta4, and alpha4beta2 nicotinic acetylcholine receptors (nAChRs) expressed in Xenopus oocytes or established cell lines. The present study evaluated bupropion-induced inhibition of native alpha3beta2* and alpha3beta4* nAChRs using functional neurotransmitter… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 34 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 49 references

Bupropion dose-dependently and selectively increases nicotine self-administration in rats

  • AS Rauhut, LP Dwoskin, MT Bardo
  • Drug Alcohol Depend 66:S144
  • 2002
1 Excerpt

Reboxetine is a selective norepinephrine transport inhibitor and a noncompetitive inhibitor of nicotinic acetylcholine receptors

  • DK Miller, EHF Wong, MD Chesnut, LP Dwoskin
  • J Pharmacol Exp Ther 302:687–695
  • 2002
1 Excerpt

Similar Papers

Loading similar papers…